Shareholding Snapshot
Shareholding Compare (%holding) 
Majority shareholders
Domestic Funds
Domestic Funds
Held in 5 Schemes (1.55%)
Foreign Institutions
Held by 6 Foreign Institutions (0.15%)
Strategic Entities with highest holding
Highest Public shareholder
Management
Designation
No Data
Revenue and Profits:
Net Sales:
1 Million
(Quarterly Results - Sep 2022)
Net Profit:
-3 Million
Pharmaceuticals & Biotechnology
USD 0 Million ()
0
NA
0.00%
-0.61
-999,999.00%
-0.00






